15 of the hedge funds we track hold GSK, worth $304.8M combined as of the Q2 2026 13F filings (preliminary, still landing).
Versus the prior quarter: 6 opened a new position, 2 added, 6 trimmed, 2 exited.
9 of those are hedged quant multi-strategy books, not directional conviction.